Eli Lilly and Company


Eli Lilly Wins EMA Nod For COVID-19 Antibody Therapy; Shares Jump 3%

Eli Lilly and Co. received praise from the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) for its antibody …

Morgan Stanley Turns Bullish On Eli Lilly, Lifts PT

Morgan Stanley upgraded Eli Lilly to Buy from Hold and raised the stock’s price target to $176 (17.7% upside potential) from $157, citing …

Merck vs Eli Lilly: Which Pharma Stock Is A Better Pick?

The pharmaceutical industry is considered to be more resilient in difficult economic times compared to other industries. However, this time around, the coronavirus-led …

Eli Lilly Starts Dosing Patients In World’s First Covid-19 Antibody Trial

Eli Lilly (LLY) has today announced patients have been dosed in the world’s first study of a potential antibody treatment designed to fight …

Eli Lilly Lowers Insulin Cost in Response to Coronavirus Pandemic

Drugmaker Eli Lilly & Co (LLY) said on Tuesday it has reduced the out-of-pocket cost for insulin to $35 per month to help …

Stock Update (NASDAQ:INCY): Incyte Corporation’s and Eli Lilly’s Baricitinib Demonstrates Superiority to Adalimumab in Improving Signs and Symptoms of Rheumatoid Arthritis in Pivotal Phase 3 Study

Incyte Corporation (NASDAQ:INCY) and Eli Lilly and Company (NYSE:LLY) announced positive topline results of RA-BEAM, the fourth successful Phase 3 study of baricitinib, an …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts